Dr. Ma received B.Sc. and M.Sc. degree in synthetic organic chemistry from Lanzhou University in 1991. He was then awarded his Ph.D degree in 2001 in synthetic organic chemistry from University of Montreal under the supervision of Professor Stephen Hanessian. After two years’ postdoctoral research at Harvard University with Professor Yoshito Kishi, he then began his career in pharmaceutical industry and held various senior scientific positions at Memory pharmaceutical, Sepracorovion and AstraZeneca where he made key contributions to many medicinal chemistry programs in CNS (Alzheimer’s disease, Depression) and Oncology (Raf/MEK dual kinase inhibitors and Antibody-Drug Conjugates, ADC) as well as process chemistry programs. In 2012, he joined Asymchem and had been VP of R&D before he took the CTO (Chief technology Officer) position with Porton in 2014. In 2017, Dr.Ma joined Shanghai Medicilon.
Shanghai Medicilon Inc.
Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China